Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

A new report identifies six Massachusetts startup "unicorns" as life science companies most likely to hold initial public ...

It will be targeted at institutional investors in the UK as well as retail investors through the Retail Book platform.

Biotech IPO activity in the US has spiked for the second time this year, following an initial boost in Q1 2024. Largely ...

Setting up and launching an initial public offering (IPO) for a special purpose acquisition Company (SPAC) generally is much ...

Oct 10 (Reuters) - Initial public offerings (IPOs) are slowly coming back in Europe after a summer lull. Polish convenience ...

Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease ...

Cerebras competes with industry leader Nvidia in the lucrative artificial intelligence chip market. The Sunnyvale, California ...

India's scrapping of a time-consuming compliance step will accelerate the pace at which Indian startups domiciled abroad ...

Japanese payments company Infcurion is planning an initial public offering in Tokyo in 2025 as the company looks to ...

The number of Americans aged 65 and older increased by 67% from 2004 to 2022, rising to 58 million, according to Guardian.

The family-owned company will continue to evaluate the possibility of listing its shares once the situation improves.